|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.00 GBX | +1.35% |
|
+5.63% | +29.31% |
| Apr. 09 | Somero Enterprises extends buyback to USD6.0 million | AN |
| Apr. 09 | Avacta hails "important milestones" in start of "transformative" year | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 455M | - | - | |||
| 52.12B | |||||
| 47.25B | |||||
| 31.67B | - | ||||
| 25.15B | - | ||||
| 19.54B |
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
